# European Innovation Council

> European Innovation Council is a VC fund backing Health Care. See 122 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Brussels, Belgium
- Total investments: 122
- Last investment: Jul 2025
- Lead investor: 54%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/eismea
- X (Twitter): https://twitter.com/EUeic
- Website: https://eic.ec.europa.eu
- Facebook: https://www.facebook.com/EIC-The-European-Innovation-Council-2462855093727279

European Innovation Council is a VC fund in Brussels focused on Health Care and Biotechnology. The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.

## Contacts

5 contacts available for European Innovation Council. Shizune tracks 20 team members at European Innovation Council. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/eic-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 27 | 22% |
| Biotechnology | 24 | 20% |
| Medical Device | 21 | 17% |
| Medical | 14 | 11% |
| Software | 11 | 9% |

104 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 37 | 30% |
| Series A | 20 | 16% |
| Pre-Seed | 16 | 13% |
| Venture - Series Unknown | 15 | 12% |
| Series B | 12 | 10% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| The Netherlands | 18 | 15% |
| Germany | 12 | 10% |
| France | 10 | 8% |
| Spain | 8 | 7% |
| Israel | 8 | 7% |

27 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ana Barjasic | Board Member | 0 | https://shizune.co/investors/profile/ana-barjasic |
| Andreas Lindblom | EBAN Health Steering Committee | 13 | https://shizune.co/investors/profile/andreas-lindblom |
| Barry Downes | Expert / Evaluator - European Innovation Council (EIC) Accelerator | 19 | https://shizune.co/investors/profile/barry-downes-2 |
| Brigitte Baumann | President Emeritus | 30 | https://shizune.co/investors/profile/brigitte-baumann |
| Candace Johnson | President | 1 | https://shizune.co/investors/profile/candace-johnson |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Scandinavian Real Hearts | Scandinavian Real Hearts is a medical technology company that develops an artificial heart that will save the lives of hard-hearted people in transplant queue.The Scandinavian Real Hearts Total Artificial Heart (TAH) is created to be the closest copy of both the normal normal pumping, normal pressure ratio, and the normal pulse. Scandinavian RealHeart develops a Total Artificial Heart, with better function than those on the market, and can primarily be used as a transitional solution for patients who are waiting for a heart transplant. | $715.1K | Post-IPO Equity | Jul 07, 2025 |  |
| BrainEver | BrainEver’s innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and control several neuronal functions, including metabolism and epigeneticstability.BrainEver makes the hypothesis that, in patients, homeoprotein administration could durably modify the physiological resistance of surviving neurons while increasing their activity, thus leading to the improvement of clinical symptoms.Different homeoproteins that could be important in different neurodegenerative pathologies are being explored, the most advanced being Engrailed 1 (BREN01) for the treatment of Parkinson Disease and Amyotrophic Lateral Sclerosis (ALS).Beside Engrailed 1 in Parkinson Disease and ALS, BrainEver is currently generating a pipeline of 4 drug candidates targeting other neurodegenerative disease like Huntington Disease and Optic Neuropathies. | $38.8M | Series B | Jul 03, 2025 |  |
| H2SITE | Systems and Membranes for high efficiency and purity Hydrogen production i.e. for Separation or Ammonia cracking |  | Grant | Jul 03, 2025 |  |
| RheEnergise | RheEnergise is bringing innovation to pumped hydro storage with High-Density Hydro®. Our mission is to create the technology that will allow for ultra-scalable long duration energy storage projects. High-Density Hydro is based on conventional pumped hydro, but utilises a high-density fluid instead of water, meaning that projects can be 2.5x smallerfor the same power. RheEnergise’s HD Hydro will be the lowest cost energy storage solution available, offering the greatest flexibility to the power grid. | $2.9M | Grant | Jul 02, 2025 |  |
| Groove Quantum | Groove Quantum is a company that develops germanium-based quantum computing technology. | $3M | Grant | Jul 01, 2025 |  |
| Groove Quantum | Groove Quantum is a company that develops germanium-based quantum computing technology. |  |  | Jul 01, 2025 |  |
| CroíValve | CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $3M | Grant | Jul 01, 2025 |  |
| Escala Medical | Escala Medical is developing the first minimally invasive, medical device for the treatment of women with pelvic organ prolapse (POP).Escala develops the first real nonsurgical, incision-free and mesh-free, repair device for the treatment of POP.Our system presents a long-overdue repair option for POP: it is safe and quick and preserves organfunctionality with minimal patient discomfort. As no incisions are required the procedure can be performed in an outpatient and office-based settings. |  |  | Jun 30, 2025 |  |
| Ever Dye | Ever Dye innovates in the fashion industry by developing ecological dyeing processes for the textile industry. | $17.5M | Series A | Jun 25, 2025 |  |
| Axiles Bionics | Axiles Bionics is a Brussels based spin-off from Brubotics (VUB – Free University Brussels), striving to improve the quality of life of people with assistive robotics. Our first focus today is with amputees and bringing the next generation bionic feet to the market. | $7M | Series A | Jun 24, 2025 |  |

10 of 122 investments shown.

## Co-investors
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 114 deals together
- [Invest-NL](https://shizune.co/investors/profile/invest-nl) — VC Fund, 5 deals together
- [Otium Capital](https://shizune.co/investors/profile/otium-capital) — VC Fund, 3 deals together
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund, 2 deals together
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 2 deals together
- [Crédit Mutuel Innovation](https://shizune.co/investors/profile/cm-cic-capital-innovation) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [Biotech Investors in Germany](https://shizune.co/investors/biotech-investors-germany)
- [Biotech VC Funds in Germany](https://shizune.co/investors/biotech-vc-funds-germany)
- [Biotechnology VC Funds in Germany](https://shizune.co/investors/biotechnology-vc-funds-germany)
- [All VC Funds in Austria](https://shizune.co/investors/vc-funds-austria)
- [All Investors in Luxembourg](https://shizune.co/investors/investors-luxembourg)
- [All VC Funds in Luxembourg](https://shizune.co/investors/vc-funds-luxembourg)

## FAQ

### What does European Innovation Council invest in?

European Innovation Council invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Series A stage. Most of the 122 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact European Innovation Council?

Public channels for European Innovation Council include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at European Innovation Council?

The team at European Innovation Council includes Ana Barjasic (Board Member), Andreas Lindblom (EBAN Health Steering Committee) and Barry Downes (Expert / Evaluator - European Innovation Council (EIC) Accelerator), among 20 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co